nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2022, 02, v.57 169-172
病理性近视是近视防控的重点和难点
基金项目(Foundation): 首都卫生发展科研专项(编号:首发2020-1-2052); 北京市科委科技计划项目(编号:Z201100005520045、Z181100001818003); 北京市医院管理局“登峰”人才培养计划(编号:DFL20150201)
邮箱(Email): weiwenbintr@163.com;
DOI: 10.19405/j.cnki.issn1000-1492.2022.02.001
发布时间: 2022-01-20
出版时间: 2022-01-20
网络发布时间: 2022-01-20
移动端阅读
摘要:

近年来,我国儿童和青少年的近视患病率持续上升,随之而来的是病理性近视发生率也不断增加。病理性近视有别于单纯的近视,是由于眼轴过度延长导致,后巩膜葡萄肿以及多种眼底改变是其主要特征,目前已成为我国重要的致盲性眼病,造成了严重的社会负担,而社会各界对其了解和关注仍十分有限。病理性近视影响因素广,并发症多,且终身进展,故而防治难度明显增加。病理性近视作为近视防控中的重点和难点,值得全社会给予高度的重视。

Abstract:

In recent years, the prevalence of myopia in children and adolescents has continued to rise in China, followed by an increasing incidence of pathological myopia. Pathological myopia results from excessive axial elongation, with posterior scleral staphyloma and various fundus changes as the main characteristics. It has become a leading cause of blindness in China, causing a serious social burden. However, the attention on pathological myopia is still limited. The prevention and treatment of pathological myopia is difficult since it has plenty of risk factors and many complications with lifelong progress. Pathological myopia, as the key and difficult point in myopia prevention and control, deserves great attention from the whole society.

参考文献

[1] Holden B A,Fricke T R,Wilson D A,et al.Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050[J].Ophthalmology,2016,123(5):1036-42.

[2] 国家卫生健康委员会.2018年儿童青少年近视调查结果和近视防控工作措施[R/OL].(2019-04-29)[2021-10-10].http://www.nhc.gov.cn/xwzb/webcontroller.do?titleSeq=11158&gecstype=1.

[3] 教育部,国家卫生健康委员会,国家体育总局,等.综合防控儿童青少年近视实施方案[J].中国学校卫生,2018,39(9):1279-80.

[4] Ohno-Matsui K.Proposed classification of posterior staphylomas based on analyses of eye shape by three-dimensional magnetic resonance imaging[J].Ophthalmology,2014,121(9):1798-809.

[5] Ohno-Matsui K,Kawasaki R,Jonas J B,et al.International photographic classification and grading system for myopic maculopathy[J].Am J Ophthalmol,2015,159(5):877-83.

[6] Chen S J,Cheng C Y,Li A F,et al.Prevalence and associated risk factors of myopic maculopathy in elderly Chinese:the Shihpai eye study[J].Invest Ophthalmol Vis Sci,2012,53(8):4868-73.

[7] Liu H H,Xu L,Wang Y X,et al.Prevalence and progression of myopic retinopathy in Chinese adults:the Beijing eye study[J].Ophthalmology,2010,117(9):1763-8.

[8] Gao L Q,Liu W,Liang Y B,et al.Prevalence and characteristics of myopic retinopathy in a rural Chinese adult population:the Handan Eye Study[J].Arch Ophthalmol,2011,129 (9):1199-204.

[9] Xu L,Wang Y,Li Y,et al.Causes of blindness and visual impairment in urban and rural areas in Beijing[J].Ophthalmology,2006,113(7):1134.e1–11.

[10] Morgan I G,Ohno-Matsui K,Saw S M.Myopia[J].Lancet,2012,379(9827):1739-48.

[11] Yan Y N,Wang Y X,Yang Y,et al.Ten-year progression of myopic maculopathy:The Beijing eye study 2001-2011[J].Ophthalmology,2018,125(8):1253-63.

[12] Edge R,Navon S.Axial length and posterior staphyloma in Saudi Arabian cataract patients[J].J Cataract Refract Surg,1999,25(1):91-5.

[13] Zhou X,Pardue M T,Iuvone P M,et al.Dopamine signaling and myopia development:What are the key challenges[J].Prog Retin Eye Res,2017,61:60-71.

[14] Arumugam B,McBrien N A.Muscarinic antagonist control of myopia:evidence for M4 and M1 receptor-based pathways in the inhibition of experimentally-induced axial myopia in the tree shrew[J].Invest Ophthalmol Vis Sci,2012,53(9):5827-37.

[15] Dong L,Shi X H,Li Y F,et al.Blockade of epidermal growth factor and its receptor and axial elongation in experimental myopia[J].FASEB J,2020,34(10):13654-70.

[16] Dong L,Shi X H,Kang Y K,et al.Amphiregulin and ocular axial length[J].Acta Ophthalmol,2019,97(3):e460-70.

基本信息:

DOI:10.19405/j.cnki.issn1000-1492.2022.02.001

中图分类号:R778.11

引用信息:

[1]魏文斌,董力.病理性近视是近视防控的重点和难点[J].安徽医科大学学报,2022,57(02):169-172.DOI:10.19405/j.cnki.issn1000-1492.2022.02.001.

基金信息:

首都卫生发展科研专项(编号:首发2020-1-2052); 北京市科委科技计划项目(编号:Z201100005520045、Z181100001818003); 北京市医院管理局“登峰”人才培养计划(编号:DFL20150201)

发布时间:

2022-01-20

出版时间:

2022-01-20

网络发布时间:

2022-01-20

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文